Citigroup Maintains Nu Skin Enterprises to Buy with Price Target $66.00

Brokerage firm Citigroup Maintains its rating on Nu Skin Enterprises(NYSE:NUS). In a research note issued to the investors, the brokerage major Raises the price-target to $66.00 per share. The shares have been rated Buy. The rating by Citigroup was issued on Sep 15, 2016.

In a different note, On Sep 21, 2016, Citigroup said it Maintains its rating on Nu Skin Enterprises. In the research note, the firm Raises the price-target to $66.00 per share. The shares have been rated ‘Buy’ by the firm. On Aug 5, 2016, Stifel Nicolaus said it Maintains its rating on Nu Skin Enterprises. In the research note, the firm Raises the price-target to $34.00 per share. The shares have been rated ‘Sell’ by the firm. On Aug 5, 2016, Citigroup said it Maintains its rating on Nu Skin Enterprises. In the research note, the firm Raises the price-target to $52.00 per share. The shares have been rated ‘Buy’ by the firm. On Aug 5, 2016, Deutsche Bank said it Maintains its rating on Nu Skin Enterprises. In the research note, the firm Raises the price-target to $55.00 per share. The shares have been rated ‘Buy’ by the firm. On Jul 25, 2016, Jefferies said it Maintains its rating on Nu Skin Enterprises. In the research note, the firm Raises the price-target to $41.00 per share. The shares have been rated ‘Hold’ by the firm.

Nu Skin Enterprises (NUS) shares turned negative on Tuesdays trading session with the shares closing down -0.79 points or -1.32% at a volume of 4,45,950. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $59.32. The peak price level was also seen at $59.32 while the days lowest was $58.1. Finally the shares closed at $58.88. The 52-week high of the shares is $60.87 while the 52-week low is $23.51. According to the latest information available, the market cap of the company is $3,294 M.

Nu Skin Enterprises(NUS) last announced its earnings results on Aug 4, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $600.48M. Analysts had an estimated revenue of $581.62M. Earnings per share were $0.79. Analysts had estimated an EPS of $0.79.

Several Insider Transactions has been reported to the SEC. On Mar 10, 2016, Ritch N Wood (CFO) purchased 7,500 shares at $33.32 per share price.Also, On Mar 7, 2016, Joseph Y Chang (Chief Scientific Officer) sold 20,000 shares at $34.21 per share price.On Aug 19, 2015, Scott E Schwerdt (President, Americas Region) sold 18,750 shares at $45.96 per share price, according to the Form-4 filing with the securities and exchange commission.

Nu Skin Enterprises Inc. is a global direct selling company marketing personal care and nutritional products in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands respectively. The Company has Pharmanex nutritional supplements and Nu Skin personal care products under its age LOC anti-aging brand. The Company offers anti-aging personal care products. Products in this category include its ageLOC Galvanic Spa System its ageLOC Galvanic Body Spa ageLOC Galvanic Spa Body Shaping Gel and ageLOC Dermatic Effects Body Contouring Lotion and its ageLOC Transformation anti-aging skin care system. The Company markets a variety of products under its Pharmanex brand. LifePak its line of micronutrient supplements. Other anti-aging nutritional supplements include its ageLOC R2 which is designed to renew and recharge the body.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Nu Skin Enterprises - Is it time to Sell?

Top Brokerage Firms are advising their investors on Nu Skin Enterprises. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.